+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge

Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge

American Journal of Tropical Medicine and Hygiene 50(3): 322-328

The gene coding for the envelope (E) glycoprotein of dengue-2 virus was cloned into baculovirus (Autographa californica nuclear polyhedrosis virus). The recombinant virus contained the entire E protein gene, preceded by 38 nucleotides from the end of the prematrix glycoprotein gene and followed by the first 83 nucleotides of nonstructural protein 1. When expressed in Spodoptera frugiperda (Sf9) cells, approximately 1 mg of recombinant E antigen was made per 10(9) cells. This antigen reacted with polyclonal, anti-dengue type-2 antibody and a dengue type-2-specific, neutralizing monoclonal antibody. BALB/c mice immunized with the recombinant antigen produced only non-neutralizing antibody against dengue-2 virus, but were partially protected against morbidity and mortality after intracranial challenge with virulent dengue-2 virus.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 002339600

Download citation: RISBibTeXText

PMID: 8147490

Related references

Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. American Journal of Tropical Medicine and Hygiene 45(2): 159-167, 1991

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge. Vaccine 18(27): 3113-3122, 2000

Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system. Journal of General Virology 78: 2723-2733, 1997

Immunization of monkeys with baculovirus recombinant-expressed dengue envelope and NS1 glycoproteins induces partial resistance to challenge with homotypic dengue virus. Vaccines 90: modern approaches to new vaccines including prevention of AIDS: 119-124, 1990

Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. Journal of Virology 64(9): 4356-4363, 1990

Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells. Archives of Virology 139(1-2): 197-207, 1994

Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice. Vaccine 26(36): 4655-4663, 2008

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection. Vaccine 13(13): 1251-1258, 1995

Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge. Vaccine 24(31-32): 5852-5861, 2006

A MVA construct expressing a secretable form of the Dengue virus 3 envelope protein protects immunized mice from dengue-induced encephalitis. Vaccine 34(50): 6120-6122, 2016

Tests in mice of a dengue vaccine candidate made of chimeric Junin virus-like particles and conserved dengue virus envelope sequences. Applied Microbiology and Biotechnology 100(1): 125-133, 2016

Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Microbial Pathogenesis 31(1): 9-19, 2001

Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Journal of Virology 62(8): 3027-3031, 1988